131 related articles for article (PubMed ID: 6374043)
1. Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma.
Sears HF; Herlyn D; Steplewski Z; Koprowski H
J Biol Response Mod; 1984; 3(2):138-50. PubMed ID: 6374043
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
Koda K; Glassy MC; McKnight ME; Yasutomi J; Saito N; Dan M; Nakajima N
Anticancer Res; 2001; 21(1B):621-7. PubMed ID: 11299816
[TBL] [Abstract][Full Text] [Related]
3. Immune function of patients with gastrointestinal carcinoma after treatment with multiple infusions of monoclonal antibody 17.1A.
Blottière HM; Maurel C; Douillard JY
Cancer Res; 1987 Oct; 47(19):5238-41. PubMed ID: 3621210
[TBL] [Abstract][Full Text] [Related]
4. Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma.
Sears HF; Herlyn D; Steplewski Z; Koprowski H
Cancer Res; 1985 Nov; 45(11 Pt 2):5910-3. PubMed ID: 4053061
[TBL] [Abstract][Full Text] [Related]
5. A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer.
Saleh MN; Khazaeli MB; Grizzle WE; Wheeler RH; Lawson S; Liu T; Russel C; Meredith R; Schlom J; LoBuglio AF
Cancer Res; 1993 Oct; 53(19):4555-62. PubMed ID: 8402627
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies specific immunotherapy of gastrointestinal tumors.
Douillard JY; Lehur PA; Vignoud J; Blottière H; Maurel C; Thedrez P; Kremer M; Le Mevel B
Hybridoma; 1986 Jul; 5 Suppl 1():S139-49. PubMed ID: 3527945
[TBL] [Abstract][Full Text] [Related]
7. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody CO17-1A and leukapheresis in immunotherapy of pancreatic cancer.
Tempero MA; Pour PM; Uchida E; Herlyn D; Steplewski Z
Hybridoma; 1986 Jul; 5 Suppl 1():S133-8. PubMed ID: 3744378
[TBL] [Abstract][Full Text] [Related]
9. Antiidiotype antibodies in cancer patients receiving monoclonal antibody to carcinoembryonic antigen.
Traub UC; DeJager RL; Primus FJ; Losman M; Goldenberg DM
Cancer Res; 1988 Jul; 48(14):4002-6. PubMed ID: 3289737
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
[TBL] [Abstract][Full Text] [Related]
11. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
[TBL] [Abstract][Full Text] [Related]
12. A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.
Samonigg H; Wilders-Truschnig M; Kuss I; Plot R; Stöger H; Schmid M; Bauernhofer T; Tiran A; Pieber T; Havelec L; Loibner H
J Immunother; 1999 Nov; 22(6):481-8. PubMed ID: 10570746
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and clinical relevance of patient immune responses to intravenous therapy with murine monoclonal antibodies conjugated to adriamycin.
Avner B; Swindell L; Sharp E; Liao SK; Ogden JR; Avner BP; Oldham RK
Mol Biother; 1991 Mar; 3(1):14-21. PubMed ID: 2069755
[TBL] [Abstract][Full Text] [Related]
14. [The study of immunotherapy of ovarian carcinoma with anti-idiotypic antibody].
Wang J; Qian H; Feng J
Zhonghua Fu Chan Ke Za Zhi; 1996 Jun; 31(6):353-6. PubMed ID: 9206171
[TBL] [Abstract][Full Text] [Related]
15. Generation of monoclonal antibodies utilizing the host anti-idiotypic network.
Hatzistilianou MN; Sivolapenko GB; Courtenay-Luck NS; Epenetos AA; Ritter MA
In Vivo; 1995; 9(2):139-44. PubMed ID: 7548789
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial of Wistar Institute 17-1A monoclonal antibody in patients with advanced gastrointestinal adenocarcinoma: a preliminary report.
Verrill H; Goldberg M; Rosenbaum R; Abbott R; Simunovic L; Steplewski Z; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S175-83. PubMed ID: 3527947
[TBL] [Abstract][Full Text] [Related]
18. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity to therapeutic murine monoclonal antibodies.
Kornbrot B; Kobayashi RH; Singer A; Tempero MA; Heiner DC
Nebr Med J; 1994 Dec; 79(12):393-8. PubMed ID: 7870212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
